相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Vaccines for leishmaniasis From proteome to vaccine candidates
Juliane Schroeder et al.
HUMAN VACCINES (2011)
Vaccines for the Leishmaniases: Proposals for a Research Agenda
Carlos Henrique Nery Costa et al.
PLOS NEGLECTED TROPICAL DISEASES (2011)
Murine visceral leishmaniasis: IgM and polyclonal B-cell activation lead to disease exacerbation
Eszter Deak et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2010)
A clinical trial to evaluate the safety and immunogenicity of the LEISH-F1+MPL-SE vaccine when used in combination with meglumine antimoniate for the treatment of cutaneous leishmaniasis
Evaldo Nascimento et al.
VACCINE (2010)
Cost-Effectiveness Analysis of Combination Therapies for Visceral Leishmaniasis in the Indian Subcontinent
Filip Meheus et al.
PLOS NEGLECTED TROPICAL DISEASES (2010)
Leishmaniasis Vaccine: Where are We Today?
Lukasz Kedzierski
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2010)
Vaccines and vaccination strategies against human cutaneous leishmaniasis
Ifeoma Okwor et al.
HUMAN VACCINES (2009)
Salmonella enterica serovar Typhi live vector vaccines finally come of age
James E. Galen et al.
IMMUNOLOGY AND CELL BIOLOGY (2009)
Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era
Eric Dumonteil
INFECTION GENETICS AND EVOLUTION (2009)
Priming of Salmonella enterica Serovar Typhi-Specific CD8+ T Cells by Suicide Dendritic Cell Cross-Presentation in Humans
Rosangela Salerno-Goncalves et al.
PLOS ONE (2009)
Proteome-Based Analysis of Serologically Defined Tumor-Associated Antigens in Cutaneous Lymphoma
Michael Forgber et al.
PLOS ONE (2009)
Efficacy of killed whole-parasite vaccines in the prevention of leishmaniasis-A meta-analysis
Sassan Noazin et al.
VACCINE (2009)
Decrease of the incidence of human and canine visceral leishmaniasis after dog vaccination with Leishmune® in Brazilian endemic areas
Clarisa B. Palatnik-de-Sousa et al.
VACCINE (2009)
KMP-11 DNA immunization significantly protects against L. donovani infection but requires exogenous IL-12 as an adjuvant for comparable protection against L. major
Suniti Bhaumik et al.
VACCINE (2009)
Recombinant outer membrane vesicles to augment antigen-specific live vaccine responses
Juliane Schroeder et al.
VACCINE (2009)
Retooling Leishmania metabolism:: from sand fly gut to human macrophage
Doron Rosenzweig et al.
FASEB JOURNAL (2008)
Correlation of T cell response and bacterial clearance in human volunteers challenged with Helicobacter pylori revealed by randomised controlled vaccination with Ty21a-based Salmonella vaccines
T. Aebischer et al.
GUT (2008)
A vaccine against Helicobacter pylori: Towards understanding the mechanism of protection
Toni Aebischer et al.
INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY (2008)
Transgenic, fluorescent Leishmania mexicana allow direct analysis of the Proteome of intracellular amastigotes
Daniel Paape et al.
MOLECULAR & CELLULAR PROTEOMICS (2008)
Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime®) and the recombinant Leish-110f®+MPL-SE® vaccine to treat canine visceral leishmaniasis
Jorge Miret et al.
VACCINE (2008)
Vaccines for leishmaniasis in the fore coming 25 years
Clarisal B. Palatnik-de-Sousa
VACCINE (2008)
An Oral Recombinant Vaccine in Dogs against Echinococcus granulosus, the Causative Agent of Human Hydatid Disease: A Pilot Study
Anne-Francoise Petavy et al.
PLOS NEGLECTED TROPICAL DISEASES (2008)
Hybrid cell vaccination resolves Leishmania donovani infection by eliciting a strong CD8+ cytotoxic T-lymphocyte response with concomitant suppression of interleukin-10 (IL-10) but not IL-4 or IL-13
Raiatava Basu et al.
INFECTION AND IMMUNITY (2007)
Visceral leishmaniasis: What are the needs for diagnosis, treatment and control?
Francois Chappuis et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Immunization with H1, HASPB1 and MML Leishmania proteins in a vaccine trial against experimental canine leishmaniasis
J. Moreno et al.
VACCINE (2007)
HLA class I-restricted T cell epitopes of the kinetoplastid membrane protein-11 presented by Leishmania donovani-infected human macrophages
Rajatava Basu et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Mapping the Antigenicity of the Parasites in Leishmania donovani Infection by Proteome Serology
Michael Forgber et al.
PLOS ONE (2006)
Cloning, characterization, and serodiagnostic evaluation of Leishmania infantum tandem repeat proteins
Yasuyuki Goto et al.
INFECTION AND IMMUNITY (2006)
From genome to vaccines for leishmaniasis:: Screening 100 novel vaccine candidates against murine Leishmania major infection
CB Stober et al.
VACCINE (2006)
Treatment options for visceral leish maniasis: a systematic review of clinical studies done in India, 1980-2004
PL Olliaro et al.
LANCET INFECTIOUS DISEASES (2005)
The wound repair response controls outcome to cutaneous leishmaniasis
A Sakthianandeswaren et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Kinetoplastid membrane protein-11 DNA vaccination induces complete protection against both pentavalent antimonial-sensitive and -resistant strains of Leishmania donovani that correlates with inducible nitric oxide synthase activity and IL-4 generation:: Evidence for mixed Th1-and Th2-like responses in visceral leishmaniasis
R Basu et al.
JOURNAL OF IMMUNOLOGY (2005)
Leishmanization: Use of an old method for evaluation of candidate vaccines against leishmaniasis
A Khamesipour et al.
VACCINE (2005)
Second-generation vaccines against leishmaniasis
RN Coler et al.
TRENDS IN PARASITOLOGY (2005)
DNA-Salmonella enterica serovar Typhimurium primer-booster vaccination biases towards T helper 1 responses and enhances protection against Leishmania major infection in mice
UG Lange et al.
INFECTION AND IMMUNITY (2004)
Antigen selection based on expression levels during infection facilitates vaccine development for an intracellular pathogen
C Rollenhagen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Natural antibodies and complement are endogenous adjuvants for vaccine-induced CD8+ T-cell responses
S Stäger et al.
NATURE MEDICINE (2003)
Concomitant induction of CD4+ and CD8+ T cell responses in volunteers immunized with Salmonella enterica serovar typhi strain CVD 908-htrA
R Salerno-Gonçalves et al.
JOURNAL OF IMMUNOLOGY (2003)
Autodisplay: Efficacious surface exposure of antigenic UreA fragments from Helicobacter pylori in Salmonella vaccine strains
K Rizos et al.
INFECTION AND IMMUNITY (2003)
Multiparameter selection of Helicobacter pylori antigens identifies two novel antigens with high protective efficacy
N Sabarth et al.
INFECTION AND IMMUNITY (2002)
Immunogenicity of χ4127 phoP- Salmonella enterica serovar Typhimurium in dogs
DS McVey et al.
VACCINE (2002)
From genomes to vaccines:: Leishmania as a model
C Stober et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY OF LONDON SERIES B-BIOLOGICAL SCIENCES (2002)
Examination of Salmonella gene expression in an infected mammalian host using the green fluorescent protein and two-colour flow cytometry
D Bumann
MOLECULAR MICROBIOLOGY (2002)
Salmonella typhimurium as a basis for a live oral Echinococcus granulosus vaccine
JA Chabalgoity et al.
VACCINE (2000)
Recombinant live Salmonella spp. for human vaccination against heterologous pathogens
D Bumann et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2000)
B cell-deficient mice are highly resistant to Leishmania donovani infection, but develop neutrophil-mediated tissue pathology
SC Smelt et al.
JOURNAL OF IMMUNOLOGY (2000)
Subunit vaccination of mice against new world cutaneous leishmaniasis: Comparison of three proteins expressed in amastigotes and six adjuvants
T Aebischer et al.
INFECTION AND IMMUNITY (2000)
Pilot study of phoP/phoQ-deleted Salmonella enterica serovar Typhimurium expressing Helicobacter pylori urease in adult volunteers
H Angelakopoulos et al.
INFECTION AND IMMUNITY (2000)
分享论文
